Drug Development for Neurodegenerative Conditions
Examine Translational Medicine as a Clinical Tool in Emerging Therapies
for Alzheimer's, ALS, Huntington's, Multiple Sclerosis and Parkinson's
Disease
April 30 - May 1, 2008 * Arlington, VA 
www.cbinet.com/neuro 

This conference brings together industry stakeholders and key thought
leaders in the CNS and neurodegenerative drug development arena. At this
conference, attendees have the opportunity to examine avenues in
bridging preclinical and clinical development, hear about approaches in
identifying biomarkers for early clinical decision making and explore
the regulatory requirements and latest strategies in the development of
long term trials for neurodegenerative conditions.  Sessions and case
studies will be heard examining emerging therapies and clinical drug
development for Alzheimer's, Huntington's, Multiple Sclerosis and
Parkinson's Disease

Mention Promo Code: HPR892 and Save $300 on your registration fee
(Discount cannot be combined with other discounts or used toward a
current registration)
For more information or to register, please contact the Center for
Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail
at cbireg@cbinet.com. 

------------------------------------------------------------------------